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Abstract Apolipoprotein E (apo E) exerts a protective effect
against atherosclerosis, related to its role in intracellular
cholesterol removal and remnants clearance. In this study we
investigated the effect of dietary and hypothyroid hypercholes-
terolemia, induced respectively by a high cholesterol diet and by
propylthiouracil, on hepatic apo E expression in Wistar male
rats. The Northern and Western blot analysis of hepatic mRNA
and protein levels showed a 2^3-fold increase of apo E in
hypercholesterolemic rats compared to controls. The incubation
of FAO rat hepatoma cells with 25-OH cholesterol and
mevalonate led to a three-fold increase of apo E mRNA,
demonstrating a direct role of cholesterol on apo E expression.
This effect was completely abolished by elevating intracellular
cAMP levels with forskolin. Immunoblot and immunofluores-
cence analysis revealed that 25-OH cholesterol/mevalonate
strongly increased also apo E protein synthesis and secretion in
FAO cells. Our data demonstrate that hypercholesterolemia,
apart of the cause (diet or hypothyroidism) induces liver apo E
expression in the rat and that this effect can be directly related,
via cAMP, to cholesterol.
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1. Introduction
Apolipoprotein E (apo E) plays an important role in lip-
oprotein metabolism through its interaction with cell surface
receptors as low density lipoprotein (LDL) receptor and LDL-
related protein receptor [1]. Recently, it has been demon-
strated that free apo E secreted by hepatocytes in the sinus-
oidal space of Disse and associated with very low density
lipoprotein (VLDL) and chylomicron remnants [2] is neces-
sary for a correct hepatic clearance of these lipoproteins and
therefore for the maintenance of normal fasting and post-
prandial lipid levels. Moreover, apo E has been suggested to
be involved in the reverse cholesterol transport [3]. The im-
portance of apo E in cholesterol homeostasis has been dem-
onstrated in transgenic mice lacking functioning apo E. They
develop hypercholesterolemia and early atherosclerosis [4].
Despite the growing evidence of the protective role exerted
by this apoprotein against atherosclerosis, the regulation of
apo E expression by plasma lipids has not yet been extensively
studied. Diet-induced hypercholesterolemia has been previ-
ously shown to enhance the hepatic expression of apo E; on
the contrary, only few reports exist describing opposite e¡ects
of n-propylthiouracil (PTU)-induced hypercholesterolemia on
hepatic apo E levels [5^7].
The aim of our study was to investigate the e¡ect of hyper-
cholesterolemia on hepatic apo E expression and to clarify the
underlying mechanism. On this purpose we used two di¡erent
models of hypercholesterolemia in the rat: (1) a dietary hyper-
cholesterolemia obtained by feeding the animals with a diet
enriched with 1.5% of cholesterol ; (2) a hypothyroid hyper-
cholesterolemia induced by PTU treatment. In both models
hypercholesterolemia strongly enhanced liver apo E expres-
sion. Furthermore, by in vitro studies using FAO cells, a rat
di¡erentiated hepatoma cell line, we demonstrated that cho-
lesterol is directly involved in the regulation of hepatic apo E
expression through a cAMP-dependent mechanism.
2. Materials and methods
2.1. Materials
25-OH cholesterol, PTU, mevalonate (MVA) and forskolin were
purchased from Sigma.
2.2. Animals, diet and treatment procedures
Sixty Wistar male rats weighing 200 þ 50 g were divided in three
groups of 20 rats each. The animals of the ¢rst (control) and second
groups were fed the commercial pellet laboratory chow. After 35 days
hypothyroidism was induced in the animals of second group by con-
tinuous administration for 25 days of 0.1% (w/v) PTU in the drinking
water. The rats of the third group were fed for 2 months a diet
enriched with 1.5% of cholesterol, the Nath diet [8]. All animals
were given diet and water ad libitum.
At the end of treatments blood was collected (after 16 h fasting) by
intracardiac puncture, under a slight diethylether anesthesia. Then the
animals were killed by cervical dislocation and livers were immediately
collected, frozen in N2 and stored at 380‡C until they were used.
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2.3. Cell culture
FAO cells, a rat hepatoma cell line, established and characterized
by Deschatrette and Weiss [9], were grown in Coon’s modi¢ed Ham’s
F12 medium containing 5% fetal calf serum (FCS) under a humidi¢ed
atmosphere composed of 95% air and 5% CO2 at 37‡C.
2.4. Western blot
Livers from each group of animals were pooled, homogenized in
10 volumes of PBS in the presence of 1 mM of PMSF and centrifuged
for 5 min at 4‡C at 900Ug. Cell extracts were prepared from subcon-
£uent cells grown in 100 mm Petri dishes. Cells were washed twice in
PBS, scraped in PBS and pelleted by centrifugation. Cell pellets were
resuspended in lysis bu¡er (10 mM Tris^HCl pH 7.2, 1 mM PMSF,
2 WM aprotinin, 10 WM leupeptin) disrupted by sonication and cen-
trifuged at 3000 rpm for 10 min at 4‡C. Fifty micrograms protein of
liver homogenates and cell supernatants were electrophoresed on 12%
SDS-PAGE, transferred to nitrocellulose membrane and blocked with
7.5% milk in TBS^Tween 20 for 1 h at room temperature. The ¢lters
were then probed with polyclonal rabbit antibodies directed against
anti rat apo E (kindly provided by Dr. E. Bond, Istituto dei Tumori
‘Pascale’, Naples) at a 1:100 dilution. Immunoreactive proteins were
detected by incubation with horseradish peroxidase-conjugated don-
key anti rabbit IgG (Amersham), using the enhanced chemilumines-
cence system (ECL, Amersham). The coe⁄cient of analytical varia-
tions of Western blot experiments was 4%.
2.5. Northern blot
Total RNA was isolated from a pool of liver samples for each
group of animals or from FAO cells by the guanidium thiocyanate-
acid phenol procedure [10]. Samples of total RNA were fractioned by
electrophoresis in a 1% agarose/2.2 M formaldehyde gel, transferred
to a nylon membrane and crosslinked by ultraviolet (UV) irradiation.
The membrane was then hybridized with a 32P-labelled 330 bp frag-
ment of rat apo E cDNA (kindly provided by Dr. J. Taylor, Glad-
stone Foundation, San Francisco, CA, USA) [11] in 7% SDS and
0.5 M Na-phosphate pH 7.2 at 60‡C. Labelling of the fragment was
done as described [12]. After 16 h the ¢lters were washed at 55‡C and
autoradiographed using Kodak XAR5 ¢lm for 16 h at 380‡C [10].
The coe⁄cient of analytical variations of Northern blot experiments
was 5%.
2.6. Densitometry
Protein and mRNA bands were quanti¢ed by densitometric scan-
ning of autoradiographs using NIH-image software.
2.7. Immuno£uorescence microscopy
FAO cells grown on coverslip glasses, were incubated for 24 h in
culture medium containing 0.2% FCS in the presence or in the ab-
sence of 1 Wg/ml 25-OH cholesterol and 0.76 mM MVA; then were
¢xed with 3.7% paraformaldehyde and permeabilized with 0.2% Tri-
ton X-100. The primary antibodies anti rat apo E were the same
utilized for Western blot experiments. The secondary antibodies
were FITC-conjugated anti rabbit IgG (sc-521, Santa Cruz, Ca,
USA). Non-speci¢c labeling was determined similarly, except that
non-immune rabbit antiserum substituted for anti apo E antibodies.
Coverslips were mounted on 50% glycerol in PBS and examined by
£uorescence microscopy [13].
2.8. Analytical determinations
Cholesterol and triglycerides were determined by the enzymatic-col-
orimetric method of Siedel et al. [14] and Wahlefeld [15], respectively.
The protein concentrations were determined according to the proce-
dure of Lowry et al. [16], using bovine serum albumin as standard.
2.9. Statistical analysis
Statistical di¡erences in cholesterol and triglyceride levels between
groups were evaluated by Student’s t-test.
3. Results
On the purpose to study the e¡ect of increased plasma
cholesterol levels on hepatic apo E expression, we induced
hypercholesterolemia in the rat using two di¡erent strategies:
by feeding the animals with a cholesterol enriched diet (Nath)
and by PTU treatment which leads to an hypothyroid status
and a consequent increase of plasma cholesterol levels [17].
Plasma cholesterol and triglyceride levels in control, Nath
diet and PTU-treated rats are reported in Table 1. Nath diet
increases plasma levels of cholesterol and triglycerides. Plasma
cholesterol levels increased also in PTU-treated rats, even if at
a lower extent, whereas the triglyceride levels decreased com-
pared to control.
In both the experimental conditions of hypercholesterole-
mia a large increase in liver apo E mRNA levels was observed
(three and two-fold in Nath and PTU treated animals, respec-
tively) (Fig. 1A). Increased levels (about two-fold) of apo E
proteins, as revealed by immunoblotting experiments, were
also evidenced in both groups of hypercholesterolemic ani-
mals (Fig. 1B).
Moreover, as also previously described [18^21], elevated
plasma apo E levels were observed in hypercholesterolemic
rats compared to controls (50% and 40% of increase in
Nath and PTU treatment, respectively).
Fig. 1. Expression of hepatic apo E in control and hypercholestero-
lemic (Nath and PTU) rats. A: Northern blot analysis of apo E
mRNA. In each lane 20 Wg of total RNA was loaded. In the top
panel the blot was probed with rat apo E cDNA. In the bottom
panel the same blot was stripped and reprobed with a rat glyceral-
dehyde phosphate dehydrogenase (GAPDH) cDNA probe, as con-
trol. B: Western blot analysis of apo E. In each lane 50 Wg of tissue
protein extracts was loaded.
Table 1
Plasma cholesterol and triglyceride levels in normal, Nath and
PTU-treated rats
Control Nath PTU
Cholesterol(mg/dl) 63 þ 8 205 þ 22a 85 þ 10b
Triglycerides (mg/dl) 140 þ 16 203 þ 20a 73 þ 9a
Values are means þ S.E.M.
aP6 0.001.
bP6 0.05, compared to control.
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In order to establish a direct role of cholesterol on apo E
expression, we performed in vitro experiments in FAO cells.
The incubation of cells with 1 Wg/ml of 25-OH cholesterol and
0.76 mM of MVA in complete medium for 24 h, led to a
three-fold increase of apo E mRNA (Fig. 2). The addition
of 25-OH cholesterol alone resulted in a slightly lower in-
crease of apo E mRNA, whereas MVA alone did not cause
any major variations (data not shown). A time-course experi-
ment showed that the e¡ect was already evident after 9 h of
incubation with 25-OH cholesterol and MVA and reached a
plateau after 24 h (data not shown). When 25-OH cholesterol
and MVA were incubated in the presence of forskolin, an
agent that elevates intracellular cAMP levels, the e¡ect was
completely abolished (Fig. 2).
Apo E protein levels, evaluated by immunoblotting experi-
ments, were downregulated when FAO cells where preincu-
bated in medium containing low FCS concentrations (0.2%)
or 5% lipoprotein de¢cient serum (LPDS); this e¡ect was
rescued by the addition of puri¢ed lipoproteins (data not
shown). The incubation of cells with 25-OH cholesterol and
MVA in 0.2% FCS containing medium led to a three-fold
increase of intracellular apo E levels ; moreover, the apo E
present in the medium, representing the major secreted apo-
protein, was also strongly increased (about three-fold) (Fig.
3). The increase in the apo E in the media can not be ascribed
to an increased cellular lysis since the levels of the cytosolic
enzyme lactic dehydrogenase (LDH) in the incubation media
of control and 25-OH-cholesterol/MVA treated cells were al-
most identical accounting for only the 0.7% of total. Intra-
cellular apo E was also evidenced by immuno£uorescence mi-
croscopy (Fig. 4). The main £uorescent signal was observed in
control cells intracellularly in a perinuclear region probably
associated with compartments of the secretory pathway. In
cells preincubated for 24 h with 25-OH cholesterol/MVA,
the intracellular £uorescent signal strongly enhanced and in
several cells a cell surface £uorescence was evidenced.
4. Discussion
In this study we showed that dietary and hypothyroid hy-
percholesterolemia induced hepatic apo E expression in the
rat. These two experimental conditions were characterized
by increased levels of plasma cholesterol but di¡er in the
ability to a¡ect plasma triglyceride levels, that are elevated
in Nath and decreased in the PTU-treated rats. This suggests
that the hypercholesterolemia, and not the other variations in
Fig. 2. Northern blot analysis of the apo E mRNA expression in
FAO cells. In each lane 20 Wg of total RNA was loaded. Cells were
preincubated in the presence or in the absence of 25-OH cholester-
ol/MVA, forskolin (Fsk) or both for 24 h in complete medium be-
fore harvesting. In the top panel the blot was probed with rat apo
E cDNA. In the bottom panel the same blot was stripped and re-
probed with a rat glyceraldheyde phosphate dehydrogenase
(GAPDH) cDNA probe, as control. The ¢gure is representative of
three independent experiments.
Fig. 3. Western blot analysis of apo E in cells and media of FAO
cells. Cells were preincubated for 24 h in the presence or in the ab-
sence of 25-OH cholesterol/MVA in 0.2% FCS. Twenty-¢ve microli-
ters of media and 50 Wg of cellular protein extracts were loaded.
The ¢gure is representative of three independent experiments.
Fig. 4. Immuno£uorescence of apo E in FAO cells. Cells were preincubated for 24 h in the absence (control) or in the presence of 25-OH cho-
lesterol and MVA before processing for immunostaining of apo E. The ¢gure is representative of three independent experiments.
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plasma lipid levels, were responsible for the induced hepatic
apo E expression.
Experiments performed in FAO cells, a rat di¡erentiated
hepatoma cell line previously characterized to express apopro-
teins and, in particular, apo E [22^24], demonstrated a direct
role of cholesterol on apo E expression. The addition of 25-
OH cholesterol and MVA to the FAO cells caused a strong
increase in Apo E mRNA and protein levels.
A down-regulation of apo E expression was observed when
cells were grown in medium containing low lipoprotein levels.
Moreover, it has been previously demonstrated [22] that lip-
oproteins or a lipoprotein-derived lipid extract induces apo E
synthesis in FAO cells. These e¡ects could be ascribed to the
cholesterol carried by plasma lipoproteins, as suggested by the
direct e¡ect exerted by cholesterol.
A transcriptional down-regulation of apo E expression by
cyclic AMP has been described [25]. We have shown that
forskolin mostly does not modify apo E mRNA levels in
FAO cells, but completely inhibits the cholesterol-induced
apo E expression, leading to the hypothesis that cAMP is
involved in this regulation. The low cAMP levels required
to observe the e¡ect of cholesterol suggest that it could induce
apo E expression by a factor that is, at the same time, neg-
atively regulated by cAMP.
The cholesterol-mediated increase of apo E expression in
FAO cells was accompanied by an increase in its secretion.
These data suggest that the elevated plasma apo E levels
found in hypercholesterolemic rats can be the consequence
of an increased hepatic secretion, considering that liver is a
major site of apo E synthesis, and as also suggested by our
previous ¢nding on increased levels of VLDL-IDL apo E
content [20].
Finally, by immuno£uorescence studies we evidenced in 25-
OH cholesterol/MVA treated cells that apo E is associated
with the cell surface. This signal could be ascribed to the
secreted free apo E bound extracellularly to the plasma mem-
brane [26]. Cell surface-associated apo E has been demon-
strated to play an important role in the binding of lipopro-
teins to the hepatic receptors and in the reverse cholesterol
transport [2]. Therefore, the increased expression and secre-
tion of apo E in hypercholesterolemic conditions could repre-
sent a protective mechanism aimed to lower the increased
plasma cholesterol levels.
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